Eton Pharmaceuticals (ETON) Tax Provisions (2022 - 2025)
Eton Pharmaceuticals (ETON) reported Tax Provisions of -$282000.0 for Q4 2025, down 424.14% on a YoY basis from $87000.0 in Q4 2024, and down 907.14% sequentially from -$28000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Tax Provisions (2022 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 4 years of Tax Provisions data on file, last reported at -$282000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions fell 424.14% year-over-year to -$282000.0; the trailing twelve-month figure through Dec 2025 stood at -$170000.0 (down 1233.33% YoY), and the FY2025 full-year result was -$170000.0, down 1233.33% from the prior year.
- Tax Provisions slipped to -$282000.0 in Q4 2025, from -$28000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $87000.0 in Q4 2024 to a low of -$1.9 million in Q4 2022.
- A 4-year average of -$243777.8 and a median of -$28000.0 in 2025 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions jumped 160.0% in 2024 and tumbled 424.14% in 2025, its largest moves.
- Tracing ETON's Tax Provisions over 4 years: stood at -$1.9 million in 2022, then soared by 92.34% to -$145000.0 in 2023, then jumped by 160.0% to $87000.0 in 2024, then plunged by 424.14% to -$282000.0 in 2025.
- Business Quant data shows ETON's Tax Provisions at -$282000.0 in Q4 2025, -$28000.0 in Q3 2025, and $66000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | -282,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -282,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | 66,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | -126,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Dec 31, 2023 | -145,000.00 |
| Dec 31, 2022 | -1.89 Mn |